Progression of leptomeningeal metastases in advanced EGFR-mutated non-small cell lung cancer

被引：0
|
作者：
Zhao, Q. [1 ]
Deng, L. [2 ,3 ]
Zhang, Y. [2 ,3 ]
Zhou, X. [2 ,3 ]
Li, Y. [2 ,3 ]
Yu, M. [2 ,3 ]
Zhou, L. [2 ,3 ]
Zou, B. [2 ,3 ]
Liu, Y. [2 ,3 ]
Lu, Y. [2 ,3 ]
机构：
[1] Sichuan Univ, West China Sch Med, West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Thorac Oncol, Ctr Canc, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1093/annonc/mdw383.42
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1242P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Systemic treatment of EGFR-mutated non-small cell lung cancer
    Czyzykowski, Rafal L.
    Wrona, Ewa K.
    Talajko, Agata
    Hasinska, Aleksandra M.
    Potemski, Piotr J.
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [22] Effectiveness of osimertinib plus chemotherapy and avastin for EGFR-mutated advanced non-small cell lung cancer with brain metastases
    Qin, H.
    Wang, S.
    Gao, F.
    Zeng, Z.
    Liu, X.
    ANNALS OF ONCOLOGY, 2021, 32 : S967 - S967
  • [23] Efficacy of Tyrosine Kinase Inhibitors in EGFR Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases
    Flippot, R.
    Auclin, E.
    Biondani, P.
    Le Rhun, E.
    Adam, J.
    Planchard, D.
    Caramella, C.
    Le Pechoux, C.
    Lacroix, L.
    Gazzah, A.
    Mezquita, L.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S467 - S467
  • [24] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] Early dose reduction of osimertinib in advanced EGFR-mutated non-small cell lung cancer
    Ferreira, Marion
    Ebia, Matthew I.
    Reckamp, Karen L.
    ANTI-CANCER DRUGS, 2024, 35 (07) : 672 - 679
  • [26] Investigating osimertinib plus chemotherapy in EGFR-mutated advanced non-small cell lung cancer
    Spagnuolo, Alessia
    Gridelli, Cesare
    EXPERT OPINION ON PHARMACOTHERAPY, 2025,
  • [27] High-dose furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study
    Chen, Haiyang
    Wang, Lili
    Wu, Yingxi
    Wu, Yufeng
    Ma, Shuxiang
    Yang, Sen
    He, Zhen
    Mo, Yuqing
    Zhang, Cuicui
    Wang, Qiming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
    Mambetsariev, Isa
    Arvanitis, Leonidas
    Fricke, Jeremy
    Pharaon, Rebecca
    Baroz, Angel R.
    Afkhami, Michelle
    Koczywas, Marianna
    Massarelli, Erminia
    Salgia, Ravi
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [29] Managing Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer
    Forde, Patrick M.
    Ettinger, David S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 528 - 532
  • [30] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Alessandro Leonetti
    Sugandhi Sharma
    Roberta Minari
    Paola Perego
    Elisa Giovannetti
    Marcello Tiseo
    British Journal of Cancer, 2019, 121 : 725 - 737
12345